The jurors’ reasons supporting the position “the NSH should recommend...” referred to the fact that prostate cancer is common, PSA tests are widely used, and “even if the PSA test is not perfect, it is the only one available”. The gene discussed is KLK3; the disease is prostate carcinoma.